Drug profile · INN
acetazolamide sodium
ACETAZOLAMIDE SODIUM
acetazolamide sodium (ACETAZOLAMIDE SODIUM) is a carbonic anhydrase xii inhibitor. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.
Drug details — acetazolamide sodium
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.89
Quick answer
acetazolamide sodium (ACETAZOLAMIDE SODIUM) is a carbonic anhydrase xii inhibitor. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Carbonic anhydrase XII inhibitor
Primary target: Carbonic anhydrase 1
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is acetazolamide sodium?
acetazolamide sodium (ACETAZOLAMIDE SODIUM) is a carbonic anhydrase xii inhibitor. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for acetazolamide sodium?
ACETAZOLAMIDE SODIUM is a marketed brand name for acetazolamide sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of acetazolamide sodium?
acetazolamide sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.